1. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression
   Riccardo Sgarra et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Insulin signaling modulates border cell movement inDrosophilaoogenesis
   Aditi Sharma et al, 2018, Development CrossRef
3. High glucose promotes breast cancer proliferation and metastasis by impairing angiotensinogen expression
   Shichao Sun et al, 2019, Biosci. Rep. CrossRef
4. High Glucose Affects the Cytotoxic Potential of Rapamycin, Metformin and Hydrogen Peroxide in Cultured Human Mesenchymal Stem Cells
   Azam Roohi et al, 2019, CMM CrossRef
5. Still Living Better through Chemistry: An Update on Caloric Restriction and Caloric Restriction Mimetics as Tools to Promote Health and Lifespan
   Carla Almendáriz-Palacios et al, 2020, IJMS CrossRef
6. Identification of carbonylated proteins from monocytic cells under diabetes‐induced stress conditions
   Divya Nair et al, 2021, Biomedical Chromatography CrossRef
7. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent
   Cláudia Silva et al, 2021, European Journal of Pharmacology CrossRef
8. null
   Robert Fried et al, 2021 CrossRef
9. High glucose: an emerging association between diabetes mellitus and cancer progression
   Suangson Supabphol et al, 2021, J Mol Med CrossRef
10. Revising Endosomal Trafficking under Insulin Receptor Activation
    Maria J. Iraburu et al, 2021, IJMS CrossRef
11. Cytotoxicity effect of secondary metabolites of Streptomyces koyangensis and Streptomyces tunisiensis isolated from saline soils of Garmsar City on human breast cancer cell line (MCF-7, IBRC C10082)
    Maryam Nikbakht et al, 2021, MEDICAL SCIENCES CrossRef
12. Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro
    Maitham A. Khajah et al, 2022, PLoS ONE CrossRef
13. Poly-L-lysine coated oral nanoemulsion for combined delivery of insulin and C-peptide
    Raval Kavit Harsiddharay et al, 2022, Journal of Pharmaceutical Sciences CrossRef
14. Formulation and characterization of insulin nanoclusters for a controlled release
    Mia Danielsen et al, 2023, International Journal of Biological Macromolecules CrossRef
15. Does insulin make breast cancer cells resistant to doxorubicin toxicity?
    Oleksandra Lykhova et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
16. In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart
    Akshay G. Mishra et al, 2023, BioDrugs CrossRef
17. Associations of low‐carbohydrate diets with breast cancer survival
    Maryam S. Farvid et al, 2023, Cancer CrossRef
18. Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression
    Samrein B. M. Ahmed et al, 2023, IJMS CrossRef
19. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway
    Tong Zhu et al, 2023, Environmental Toxicology CrossRef
20. Anticancer activity of the ethylacetate fraction of Vernonia amygdalina Delile towards overexpression of HER-2 breast cancer cell lines
    Poppy Anjelisa Zaitun Hasibuan et al, 2024, PHAR CrossRef